Related Experiment Video
Updated: Apr 11, 2026

In vitro Organoid Culture of Primary Mouse Colon Tumors
Published on: May 17, 2013
Dragon (repulsive guidance molecule b, RGMb) is a novel gene that promotes colorectal cancer growth
Ying Shi1, Guo-Bin Chen1, Xiao-Xiao Huang1
1Department of Gastroenterology, Zhongshan Hospital, Xiamen University, Xiamen, Fujian Province, China.
Abstract:
Colorectal cancer (CRC) is one of the most commonly diagnosed cancers and a major cause of cancer death. However, the molecular mechanisms underlying CRC initiation, growth and metastasis are poorly understood. Dragon (RGMb), a member of the repulsive guidance molecule (RGM) family, has been recently identified as a co-receptor for bone morphogenetic protein (BMP) signaling, but the role of Dragon in CRC development is undefined. Here, we show that Dragon expression was increased in colon cancer tissues compared to control tissues in CAC mouse model and in human patients. Dragon promoted proliferation of CT26.WT and CMT93 colon cancer cells and accelerated tumor growth in the xenograft mouse model. Dragon's action on colon cancer development was mediated via the BMP4-Smad1/5/8 and Erk1/2 pathways. Therefore, our results have revealed that Dragon is a novel gene that promotes CRC growth through the BMP pathway. Dragon may be exploited as a potential therapeutic target for CRC treatment.
Insights
Dragon, a repulsive guidance molecule, promotes colorectal cancer (CRC) growth by activating bone morphogenetic protein (BMP) signaling. This finding reveals Dragon as a potential therapeutic target for treating CRC.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Colorectal cancer (CRC) is a leading cause of cancer death, with poorly understood molecular drivers.
- Dragon (RGMb), a repulsive guidance molecule, acts as a bone morphogenetic protein (BMP) co-receptor.
- The role of Dragon in colorectal cancer development remains undefined.
Purpose of the Study:
- To investigate the role of Dragon in colorectal cancer initiation, growth, and metastasis.
- To elucidate the molecular pathways through which Dragon influences colorectal cancer progression.
Main Methods:
- Dragon expression analysis in colon cancer tissues from a CAC mouse model and human patients.
- In vitro proliferation assays using CT26.WT and CMT93 colon cancer cells.
- In vivo tumor growth assessment in a xenograft mouse model.
- Analysis of BMP4-Smad1/5/8 and Erk1/2 signaling pathways.
Main Results:
- Dragon expression is significantly increased in colon cancer tissues compared to controls.
- Dragon overexpression enhances colon cancer cell proliferation and accelerates tumor growth.
- Dragon mediates its effects on colorectal cancer via the BMP4-Smad1/5/8 and Erk1/2 pathways.
Conclusions:
- Dragon is a novel gene that promotes colorectal cancer growth.
- Dragon's pro-tumorigenic activity is linked to BMP signaling.
- Dragon represents a potential therapeutic target for colorectal cancer treatment.
More Related Videos
Related Concept Videos
Cancer Cell Migration through Invadopodia
Abnormal Proliferation
Chemotaxis and Direction of Cell Migration
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

